This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Lipids and Lipid Disorders  • Diabetes Mellitus  • Alert me on articles by topic

Richard Trubo

JAMA. 2005;294:670.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

San Diego—With cardiovascular disease as the principal complication in type 2 diabetes mellitus, it is not surprising that many physicians focus on aggressive modification of cardiovascular risk factors in their diabetic patients, including treating elevated lipid levels and hypertension. But at a symposium on lipid level targets for coronary heart disease in patients with diabetes, at the American Diabetes Association’s 65th Scientific Sessions here in June, Neil J. Stone, MD, professor of medicine at Northwestern University School of Medicine, Chicago, cautioned that clinical judgment is important in deciding what medications to prescribe and when to prescribe them in this patient group.

The weight of the evidence indicates the benefits of effectively managing high blood cholesterol and other risk factors in type 2 diabetes. In recently published findings from the ASCOT-LLA (Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm) trial, involving more than 2500 patients with type 2 diabetes and . . . [Full Text of this Article]